Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: Implications for angiogenic switch regulation
- 1 December 2000
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 29 (4), 236-250
- https://doi.org/10.1002/1098-2744(200012)29:4<236::aid-mc1006>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intakeMolecular Carcinogenesis, 1999
- Lessons from Basic Research in Selenium and Cancer PreventionJournal of Nutrition, 1998
- Chemopreventive AgentsPharmacology & Therapeutics, 1998
- Angiogenesis and Tumor MetastasisAnnual Review of Medicine, 1998
- Protective role of selenium against hepatitis B virus and primary liver cancer in QidongBiological Trace Element Research, 1997
- Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the SkinJAMA, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- How Tumors Become AngiogenicAdvances in Cancer Research, 1996
- The Linxian trials: mortality rates by vitamin-mineral intervention groupThe American Journal of Clinical Nutrition, 1995
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971